The global market for Intravenous Human Immunoglobulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Intravenous Human Immunoglobulin

North American market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Intravenous Human Immunoglobulin include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Human Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Human Immunoglobulin.

The Intravenous Human Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Human Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous Human Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Human Immunoglobulin Market Report

Report Metric	Details
Report Name	Intravenous Human Immunoglobulin Market
Segment by Type	Liquid Powder
Segment by Application	Hospital Specialty Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Tiantan Biological(Sinopharm), Taibang Biologic Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Human Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Human Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intravenous Human Immunoglobulin Market report?

Ans: The main players in the Intravenous Human Immunoglobulin Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Tiantan Biological(Sinopharm), Taibang Biologic Group

What are the Application segmentation covered in the Intravenous Human Immunoglobulin Market report?

Ans: The Applications covered in the Intravenous Human Immunoglobulin Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Intravenous Human Immunoglobulin Market report?

Ans: The Types covered in the Intravenous Human Immunoglobulin Market report are Liquid, Powder

1 Intravenous Human Immunoglobulin Market Overview

1.1 Product Definition

1.2 Intravenous Human Immunoglobulin by Type

1.2.1 Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2024 VS 2031)

1.2.2 Liquid

1.2.3 Powder

1.3 Intravenous Human Immunoglobulin by Application

1.3.1 Global Intravenous Human Immunoglobulin Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Specialty Clinic

1.3.4 Others

1.4 Global Intravenous Human Immunoglobulin Market Size Estimates and Forecasts

1.4.1 Global Intravenous Human Immunoglobulin Revenue 2020-2031

1.4.2 Global Intravenous Human Immunoglobulin Sales 2020-2031

1.4.3 Global Intravenous Human Immunoglobulin Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Intravenous Human Immunoglobulin Market Competition by Manufacturers

2.1 Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2020-2025)

2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Intravenous Human Immunoglobulin Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Type & Application

2.7 Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry

2.8 Global Intravenous Human Immunoglobulin Market Competitive Situation and Trends

2.8.1 Global Intravenous Human Immunoglobulin Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Intravenous Human Immunoglobulin Players Market Share by Revenue

2.8.3 Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Intravenous Human Immunoglobulin Market Scenario by Region

3.1 Global Intravenous Human Immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Intravenous Human Immunoglobulin Sales by Region: 2020-2031

3.2.1 Global Intravenous Human Immunoglobulin Sales by Region: 2020-2025

3.2.2 Global Intravenous Human Immunoglobulin Sales by Region: 2026-2031

3.3 Global Intravenous Human Immunoglobulin Revenue by Region: 2020-2031

3.3.1 Global Intravenous Human Immunoglobulin Revenue by Region: 2020-2025

3.3.2 Global Intravenous Human Immunoglobulin Revenue by Region: 2026-2031

3.4 North America Intravenous Human Immunoglobulin Market Facts & Figures by Country

3.4.1 North America Intravenous Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Intravenous Human Immunoglobulin Sales by Country (2020-2031)

3.4.3 North America Intravenous Human Immunoglobulin Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Intravenous Human Immunoglobulin Market Facts & Figures by Country

3.5.1 Europe Intravenous Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Intravenous Human Immunoglobulin Sales by Country (2020-2031)

3.5.3 Europe Intravenous Human Immunoglobulin Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Intravenous Human Immunoglobulin Market Facts & Figures by Region

3.6.1 Asia Pacific Intravenous Human Immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Intravenous Human Immunoglobulin Sales by Region (2020-2031)

3.6.3 Asia Pacific Intravenous Human Immunoglobulin Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Intravenous Human Immunoglobulin Market Facts & Figures by Country

3.7.1 Latin America Intravenous Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Intravenous Human Immunoglobulin Sales by Country (2020-2031)

3.7.3 Latin America Intravenous Human Immunoglobulin Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Intravenous Human Immunoglobulin Market Facts & Figures by Country

3.8.1 Middle East and Africa Intravenous Human Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Intravenous Human Immunoglobulin Sales by Country (2020-2031)

3.8.3 Middle East and Africa Intravenous Human Immunoglobulin Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Intravenous Human Immunoglobulin Sales by Type (2020-2031)

4.1.1 Global Intravenous Human Immunoglobulin Sales by Type (2020-2025)

4.1.2 Global Intravenous Human Immunoglobulin Sales by Type (2026-2031)

4.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2020-2031)

4.2 Global Intravenous Human Immunoglobulin Revenue by Type (2020-2031)

4.2.1 Global Intravenous Human Immunoglobulin Revenue by Type (2020-2025)

4.2.2 Global Intravenous Human Immunoglobulin Revenue by Type (2026-2031)

4.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2020-2031)

4.3 Global Intravenous Human Immunoglobulin Price by Type (2020-2031)

5 Segment by Application

5.1 Global Intravenous Human Immunoglobulin Sales by Application (2020-2031)

5.1.1 Global Intravenous Human Immunoglobulin Sales by Application (2020-2025)

5.1.2 Global Intravenous Human Immunoglobulin Sales by Application (2026-2031)

5.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Application (2020-2031)

5.2 Global Intravenous Human Immunoglobulin Revenue by Application (2020-2031)

5.2.1 Global Intravenous Human Immunoglobulin Revenue by Application (2020-2025)

5.2.2 Global Intravenous Human Immunoglobulin Revenue by Application (2026-2031)

5.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2020-2031)

5.3 Global Intravenous Human Immunoglobulin Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Baxter Intravenous Human Immunoglobulin Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Grifols Intravenous Human Immunoglobulin Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 CSL

6.3.1 CSL Company Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.3.4 CSL Intravenous Human Immunoglobulin Product Portfolio

6.3.5 CSL Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Intravenous Human Immunoglobulin Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Biotest

6.5.1 Biotest Company Information

6.5.2 Biotest Description and Business Overview

6.5.3 Biotest Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Biotest Intravenous Human Immunoglobulin Product Portfolio

6.5.5 Biotest Recent Developments/Updates

6.6 Kedrion

6.6.1 Kedrion Company Information

6.6.2 Kedrion Description and Business Overview

6.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Kedrion Intravenous Human Immunoglobulin Product Portfolio

6.6.5 Kedrion Recent Developments/Updates

6.7 Hualan Bio

6.7.1 Hualan Bio Company Information

6.7.2 Hualan Bio Description and Business Overview

6.7.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Hualan Bio Intravenous Human Immunoglobulin Product Portfolio

6.7.5 Hualan Bio Recent Developments/Updates

6.8 CNBG

6.8.1 CNBG Company Information

6.8.2 CNBG Description and Business Overview

6.8.3 CNBG Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.8.4 CNBG Intravenous Human Immunoglobulin Product Portfolio

6.8.5 CNBG Recent Developments/Updates

6.9 Shanghai RAAS

6.9.1 Shanghai RAAS Company Information

6.9.2 Shanghai RAAS Description and Business Overview

6.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Product Portfolio

6.9.5 Shanghai RAAS Recent Developments/Updates

6.10 CBPO

6.10.1 CBPO Company Information

6.10.2 CBPO Description and Business Overview

6.10.3 CBPO Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.10.4 CBPO Intravenous Human Immunoglobulin Product Portfolio

6.10.5 CBPO Recent Developments/Updates

6.11 LFB Group

6.11.1 LFB Group Company Information

6.11.2 LFB Group Description and Business Overview

6.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.11.4 LFB Group Intravenous Human Immunoglobulin Product Portfolio

6.11.5 LFB Group Recent Developments/Updates

6.12 BPL

6.12.1 BPL Company Information

6.12.2 BPL Description and Business Overview

6.12.3 BPL Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.12.4 BPL Intravenous Human Immunoglobulin Product Portfolio

6.12.5 BPL Recent Developments/Updates

6.13 Tiantan Biological(Sinopharm)

6.13.1 Tiantan Biological(Sinopharm) Company Information

6.13.2 Tiantan Biological(Sinopharm) Description and Business Overview

6.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Portfolio

6.13.5 Tiantan Biological(Sinopharm) Recent Developments/Updates

6.14 Taibang Biologic Group

6.14.1 Taibang Biologic Group Company Information

6.14.2 Taibang Biologic Group Description and Business Overview

6.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Product Portfolio

6.14.5 Taibang Biologic Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Intravenous Human Immunoglobulin Industry Chain Analysis

7.2 Intravenous Human Immunoglobulin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Intravenous Human Immunoglobulin Production Mode & Process Analysis

7.4 Intravenous Human Immunoglobulin Sales and Marketing

7.4.1 Intravenous Human Immunoglobulin Sales Channels

7.4.2 Intravenous Human Immunoglobulin Distributors

7.5 Intravenous Human Immunoglobulin Customer Analysis

8 Intravenous Human Immunoglobulin Market Dynamics

8.1 Intravenous Human Immunoglobulin Industry Trends

8.2 Intravenous Human Immunoglobulin Market Drivers

8.3 Intravenous Human Immunoglobulin Market Challenges

8.4 Intravenous Human Immunoglobulin Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Tiantan Biological(Sinopharm)

Taibang Biologic Group

List of Tables

Table 1. Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Intravenous Human Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Intravenous Human Immunoglobulin Market Competitive Situation by Manufacturers in 2024

Table 4. Global Intravenous Human Immunoglobulin Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Intravenous Human Immunoglobulin Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Type & Application

Table 12. Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Intravenous Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Human Immunoglobulin as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Intravenous Human Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Intravenous Human Immunoglobulin Sales by Region (2020-2025) & (K Units)

Table 18. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2020-2025)

Table 19. Global Intravenous Human Immunoglobulin Sales by Region (2026-2031) & (K Units)

Table 20. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2026-2031)

Table 21. Global Intravenous Human Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2020-2025)

Table 23. Global Intravenous Human Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2026-2031)

Table 25. North America Intravenous Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Intravenous Human Immunoglobulin Sales by Country (2020-2025) & (K Units)

Table 27. North America Intravenous Human Immunoglobulin Sales by Country (2026-2031) & (K Units)

Table 28. North America Intravenous Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Intravenous Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Intravenous Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Intravenous Human Immunoglobulin Sales by Country (2020-2025) & (K Units)

Table 32. Europe Intravenous Human Immunoglobulin Sales by Country (2026-2031) & (K Units)

Table 33. Europe Intravenous Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Intravenous Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Intravenous Human Immunoglobulin Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Intravenous Human Immunoglobulin Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravenous Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Intravenous Human Immunoglobulin Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Intravenous Human Immunoglobulin Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Intravenous Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Intravenous Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Intravenous Human Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Intravenous Human Immunoglobulin Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Intravenous Human Immunoglobulin Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Intravenous Human Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Intravenous Human Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Intravenous Human Immunoglobulin Sales (K Units) by Type (2020-2025)

Table 51. Global Intravenous Human Immunoglobulin Sales (K Units) by Type (2026-2031)

Table 52. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2020-2025)

Table 53. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2026-2031)

Table 54. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2020-2025)

Table 57. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2026-2031)

Table 58. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2020-2025)

Table 59. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2026-2031)

Table 60. Global Intravenous Human Immunoglobulin Sales (K Units) by Application (2020-2025)

Table 61. Global Intravenous Human Immunoglobulin Sales (K Units) by Application (2026-2031)

Table 62. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2020-2025)

Table 63. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2026-2031)

Table 64. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2020-2025)

Table 67. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2026-2031)

Table 68. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2020-2025)

Table 69. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2026-2031)

Table 70. Baxter Company Information

Table 71. Baxter Description and Business Overview

Table 72. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Baxter Intravenous Human Immunoglobulin Product

Table 74. Baxter Recent Developments/Updates

Table 75. Grifols Company Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Grifols Intravenous Human Immunoglobulin Product

Table 79. Grifols Recent Developments/Updates

Table 80. CSL Company Information

Table 81. CSL Description and Business Overview

Table 82. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. CSL Intravenous Human Immunoglobulin Product

Table 84. CSL Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Octapharma Intravenous Human Immunoglobulin Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Biotest Company Information

Table 91. Biotest Description and Business Overview

Table 92. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Biotest Intravenous Human Immunoglobulin Product

Table 94. Biotest Recent Developments/Updates

Table 95. Kedrion Company Information

Table 96. Kedrion Description and Business Overview

Table 97. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Kedrion Intravenous Human Immunoglobulin Product

Table 99. Kedrion Recent Developments/Updates

Table 100. Hualan Bio Company Information

Table 101. Hualan Bio Description and Business Overview

Table 102. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Hualan Bio Intravenous Human Immunoglobulin Product

Table 104. Hualan Bio Recent Developments/Updates

Table 105. CNBG Company Information

Table 106. CNBG Description and Business Overview

Table 107. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. CNBG Intravenous Human Immunoglobulin Product

Table 109. CNBG Recent Developments/Updates

Table 110. Shanghai RAAS Company Information

Table 111. Shanghai RAAS Description and Business Overview

Table 112. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Shanghai RAAS Intravenous Human Immunoglobulin Product

Table 114. Shanghai RAAS Recent Developments/Updates

Table 115. CBPO Company Information

Table 116. CBPO Description and Business Overview

Table 117. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. CBPO Intravenous Human Immunoglobulin Product

Table 119. CBPO Recent Developments/Updates

Table 120. LFB Group Company Information

Table 121. LFB Group Description and Business Overview

Table 122. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. LFB Group Intravenous Human Immunoglobulin Product

Table 124. LFB Group Recent Developments/Updates

Table 125. BPL Company Information

Table 126. BPL Description and Business Overview

Table 127. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. BPL Intravenous Human Immunoglobulin Product

Table 129. BPL Recent Developments/Updates

Table 130. Tiantan Biological(Sinopharm) Company Information

Table 131. Tiantan Biological(Sinopharm) Description and Business Overview

Table 132. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product

Table 134. Tiantan Biological(Sinopharm) Recent Developments/Updates

Table 135. Taibang Biologic Group Company Information

Table 136. Taibang Biologic Group Description and Business Overview

Table 137. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Taibang Biologic Group Intravenous Human Immunoglobulin Product

Table 139. Taibang Biologic Group Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Intravenous Human Immunoglobulin Distributors List

Table 143. Intravenous Human Immunoglobulin Customers List

Table 144. Intravenous Human Immunoglobulin Market Trends

Table 145. Intravenous Human Immunoglobulin Market Drivers

Table 146. Intravenous Human Immunoglobulin Market Challenges

Table 147. Intravenous Human Immunoglobulin Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Intravenous Human Immunoglobulin

Figure 2. Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravenous Human Immunoglobulin Market Share by Type: 2024 & 2031

Figure 4. Liquid Product Picture

Figure 5. Powder Product Picture

Figure 6. Global Intravenous Human Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Intravenous Human Immunoglobulin Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Specialty Clinic

Figure 10. Others

Figure 11. Global Intravenous Human Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Intravenous Human Immunoglobulin Market Size (2020-2031) & (US$ Million)

Figure 13. Global Intravenous Human Immunoglobulin Sales (2020-2031) & (K Units)

Figure 14. Global Intravenous Human Immunoglobulin Average Price (USD/Unit) & (2020-2031)

Figure 15. Intravenous Human Immunoglobulin Report Years Considered

Figure 16. Intravenous Human Immunoglobulin Sales Share by Manufacturers in 2024

Figure 17. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Intravenous Human Immunoglobulin Players: Market Share by Revenue in Intravenous Human Immunoglobulin in 2024

Figure 19. Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Intravenous Human Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Intravenous Human Immunoglobulin Sales Market Share by Country (2020-2031)

Figure 22. North America Intravenous Human Immunoglobulin Revenue Market Share by Country (2020-2031)

Figure 23. United States Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2020-2031)

Figure 26. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2020-2031)

Figure 27. Germany Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Intravenous Human Immunoglobulin Revenue Market Share by Region (2020-2031)

Figure 34. China Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Intravenous Human Immunoglobulin Sales Market Share by Country (2020-2031)

Figure 44. Latin America Intravenous Human Immunoglobulin Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Intravenous Human Immunoglobulin Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Intravenous Human Immunoglobulin Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Intravenous Human Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Intravenous Human Immunoglobulin by Type (2020-2031)

Figure 54. Global Revenue Market Share of Intravenous Human Immunoglobulin by Type (2020-2031)

Figure 55. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Intravenous Human Immunoglobulin by Application (2020-2031)

Figure 57. Global Revenue Market Share of Intravenous Human Immunoglobulin by Application (2020-2031)

Figure 58. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2020-2031)

Figure 59. Intravenous Human Immunoglobulin Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions